Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Mitochondrial CIV Assembly WP4922,-0.5286586350990145,-2.0801846475037467,0.0,0.004935834155972358,0.02,13/35,23.20%,COX5B;PET100;COX14;COX7C;COX5A;CMC1;COX20;COX6A1;SCO2;COX6B1;COX7B;SMIM20;COX4I1
prerank,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.6273127973589265,1.810208018930056,0.013513513513513514,0.259617654000472,0.17,9/74,23.55%,ACTG1;ACTN1;CTNNB1;ITGB4;DSG2;LMNA;ATP2A2;ITGB1;ACTN4
prerank,Tumor suppressor activity of SMARCB1 WP4204,0.6385772674374258,1.8050693439164387,0.0,0.14160962945480293,0.19,7/31,9.64%,H3F3B;ACTL6A;SMARCD2;ARID1A;CDKN2A;SMARCC1;SMARCE1
prerank,Endoderm differentiation WP2853,0.48110089339381495,1.7619066053135228,0.0,0.2006136417276375,0.32,21/141,31.01%,APP;RTF1;CDYL;CTNNB1;PIAS1;CAND1;PABPC1;CTR9;PHF6;DKK1;CUL4B;BPTF;LAMC1;PARP8;AHDC1;FOXA1;MAP2K3;STAT1;LRPPRC;CTBP2;AEBP2
prerank,Pathogenic Escherichia coli infection WP2272,0.570555489749606,1.7552650196771964,0.0,0.15931083313665328,0.34,14/55,23.47%,NCK1;ACTG1;YWHAZ;ROCK1;CTNNB1;TUBA4A;ARPC3;ARPC2;ARPC1B;YWHAQ;CDH1;FYN;ITGB1;ARPC5
prerank,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.5391163817666427,1.7460504624285174,0.0,0.13688930847297615,0.37,14/47,31.54%,MAP4K5;ACTG1;CTNNB1;TEAD1;STK3;ITGB4;YWHAQ;MAPK8;CDH1;ITGB1;PAK1;TEAD2;ACTB;SAV1
prerank,Focal Adhesion WP306,0.43656615042395663,1.7337576773236367,0.0,0.12390842577295257,0.39,37/198,23.87%,LAMA3;MYL12B;CAV1;SHC1;MYL12A;AKT2;ACTG1;ERBB2;ARHGAP35;PPP1CB;FN1;DIAPH1;ROCK1;ACTN1;CTNNB1;LAMA5;PPP1R12A;FLNA;MAPK3;ARHGAP5;PDGFB;SOS1;ITGB4;MAPK8;LAMC1;CRK;FYN;PIK3CB;IGF1R;THBS1;RAP1B;AKT1;GRB2;PTK2;ITGB1;ACTN4;VCL
prerank,Ebola Virus Pathway on Host WP4217,0.4494045530777161,1.697082584410992,0.0,0.15846791867561277,0.47,26/129,26.91%,CAV1;RHOC;ACTG1;ADAM17;RAB5A;ACTN1;RAB7A;FLNA;MAPK3;VPS41;AXL;TSG101;TBK1;IRF3;PIK3CB;IGF1R;NPC1;AKT1;PRKRA;CLTC;ITGB1;ACTN4;KPNA1;PAK1;RFC1;STAT1
prerank,Exercise-induced Circadian Regulation WP410,0.5722347176261418,1.6850311308534283,0.0,0.15931083313665328,0.52,7/48,15.57%,EIF4G2;VAPA;TAB2;NCOA4;NCKAP1;UGP2;SUMO1
prerank,TGF-beta Signaling Pathway WP366,0.4221925689407518,1.6686871102162875,0.0,0.1547216321820995,0.55,27/132,23.18%,CAV1;SHC1;APP;JUND;SKP1;FN1;ROCK1;PIAS1;SIN3A;TGFBR2;NUP153;SOS1;ITGB4;MAP2K4;TGIF1;WWP1;MAPK8;SUMO1;MAPK14;THBS1;AKT1;GRB2;PPM1A;PTK2;YAP1;ATF3;ITGB1
prerank,EGF/EGFR signaling pathway WP437,0.4177734114285292,1.6611254519331624,0.0,0.15105027141845645,0.58,39/162,28.69%,CAV1;SHC1;PTPN12;AP2M1;JUND;NCK1;ERBB2;USP8;RAB5A;ROCK1;RASA1;STAMBP;AP2B1;ASAP1;SOS1;CFL1;PRKCI;MAPK8;INPPL1;STMN1;CRK;PXDN;RPS6KA3;JAK1;MAPK14;IQSEC1;EPS8;RICTOR;AKT1;GRB2;PLSCR1;ATXN2;PTK2;AP2S1;PAK1;MAP3K2;STAT1;RALBP1;ITCH
prerank,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.4784014720924759,1.6203368746528317,0.023529411764705882,0.21348724440534683,0.72,16/72,26.60%,NCK1;CTNNB1;LAMA5;MYO1E;ITGB4;YWHAQ;DKK1;FYN;CD2AP;AKT1;PTK2;ITGB1;ACTN4;VCL;LIMS1;SMARCAL1
prerank,Pathways affected in adenoid cystic carcinoma WP3651,0.4934380130796174,1.615982184333148,0.0,0.202580442136732,0.73,11/65,19.80%,MORF4L1;ERBB2;ARID1A;DTX4;SMARCE1;TLK1;SETD2;NSD1;SRCAP;AKT1;KANSL1
prerank,Parkinson's disease pathway WP2371,0.5954137173548132,1.608122810717823,0.04225352112676056,0.20424465786750423,0.76,9/38,25.98%,UBB;UCHL1;CASP2;UBE2J2;UBE2G1;MAPK14;ATXN2;PARK7;HTRA2
prerank,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.47406637795184686,1.6038586609359589,0.011904761904761904,0.20145655618867797,0.76,18/68,25.08%,IKBKG;NCK1;ERBB2;FN1;RASA1;CTNNB1;MAPK3;SOS1;MAPK8;STMN1;CRK;MAPK14;AKT1;GRB2;PTK2;YAP1;ITGB1;PAK1
prerank,Regulation of Actin Cytoskeleton WP51,0.4162465930106813,1.5925988703930336,0.011904761904761904,0.210054283691291,0.78,25/150,25.08%,RRAS2;ACTG1;ARHGAP35;FN1;DIAPH1;ROCK1;ACTN1;BAIAP2;NCKAP1;RDX;PPP1R12A;MAPK3;PDGFB;SOS1;CFL1;PIK3C3;CRK;PIK3CB;ENAH;WASF1;PTK2;ARPC5;GNA12;VCL;PAK1
prerank,Circadian rhythm related genes WP3594,0.4184750090715697,1.5815552898406153,0.0,0.2153646447958461,0.81,24/201,24.83%,NAMPT;HNRNPU;DDX5;CSNK1D;JUND;NONO;SKP1;PRKAA1;MAGED1;AHR;PPP1CB;ARNTL2;SIN3A;GFPT1;CSNK1E;THRAP3;MAPK8;AHCY;CCAR2;SETX;KDM5A;CDK4;OGT;NCOR1
prerank,Corticotropin-releasing hormone signaling pathway WP2355,0.4712451792352208,1.5776031151788945,0.0,0.20894361993086116,0.81,13/93,21.68%,JUND;GNAS;TRIM28;CTNNB1;MAPK3;PRKCI;ECE1;MAPK8;MAPK14;HSP90AA1;RAP1B;AKT1;PTK2
prerank,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.4588640501508894,1.5760074604154906,0.022988505747126436,0.19864684131854302,0.82,16/66,28.03%,SHC1;NCK1;ERBB2;FN1;CTNNB1;DVL1;DAAM1;SOS1;MAP2K4;MAPK8;AKT1;GRB2;PTK2;PAK1;ACTR2;FZD6
prerank,Regulation of Microtubule Cytoskeleton WP2038,0.5382323998110066,1.567053794449634,0.05333333333333334,0.19999254686160764,0.83,15/46,36.22%,DIAPH1;ROCK1;DVL1;STMN1;MARK2;TRIO;AKT1;PRKACA;MAP1B;PTPRA;CLIP1;PAK1;RAC1;CFL2;PHLDB2
prerank,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.502715078832995,1.5627642546698446,0.0,0.19648336086853904,0.83,14/46,26.27%,CSNK2A1;EIF4A1;EIF4G1;AKT2;MAPK3;MAP2K4;EIF4A2;MAPK8;PIK3CB;MAPK14;AKT1;PRKACA;EIF4G3;MAP2K3
prerank,Translation Factors WP107,0.45877177489320636,1.5539468273763217,0.011627906976744186,0.20117558470166447,0.84,11/52,13.68%,EEF1D;EIF4A1;EIF4G1;PAIP1;EEF1A1;EIF3CL;EIF3E;EIF3H;PABPC1;EIF5;EIF4A2
prerank,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.4185766596418557,1.5535990459036249,0.01098901098901099,0.19256764005406915,0.84,25/132,28.23%,SHC1;MAP4K5;AKT2;PRKAA1;MAPK3;MAP3K13;SOS1;MAP2K4;PIK3C3;MAPK8;CAP1;CRK;RPS6KA3;PIK3CB;MAPK14;RICTOR;AKT1;MINK1;MAPKAP1;MAP3K2;EXOC7;MAP2K3;MAP3K14;PIK3C2A;FBP1
prerank,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.5188437188624245,1.5401448677752743,0.023809523809523808,0.21087520907943477,0.87,14/62,27.26%,IKBKG;NCK1;AHSA1;DLG1;MAPK3;SOS1;FYN;BCL10;AKT1;GRB2;CDK4;PAK1;CALM1;MAP3K14
prerank,Hepatitis B infection WP4666,0.41640988942381185,1.5363925513969139,0.022988505747126436,0.20651404295492093,0.88,25/152,26.93%,DDX3X;IKBKG;AKT2;YWHAZ;TAB2;IFNAR1;MAPK3;TGFBR2;SOS1;MAP2K4;TBK1;YWHAQ;MAPK8;IRF3;PIK3CB;JAK1;MAPK14;AKT1;GRB2;BID;YWHAB;ATP6AP1;MAP2K3;STAT1;TYK2
prerank,Alpha 6 Beta 4 signaling pathway WP244,0.5388810671232012,1.528265428010817,0.0379746835443038,0.2058059948076469,0.89,11/33,21.68%,LAMA3;SHC1;LAMA5;MAPK3;SOS1;ITGB4;LAMC1;MAPK14;AKT1;GRB2;PTK2
prerank,Pathways Regulating Hippo Signaling WP4540,0.4571043237898086,1.5280461073143774,0.02564102564102564,0.19789037962273742,0.89,17/98,42.28%,GNAS;PRKAA1;CTNNB1;TEAD1;STK3;PRKCI;CDH1;IGF1R;PRKACA;PRKD3;TEAD2;MET;RAC1;EGFR;SMAD3;TAZ;PRKAR1A
prerank,Acute viral myocarditis WP4298,0.45531972081562205,1.5230891336012433,0.047058823529411764,0.19799124118217817,0.9,15/86,19.92%,CAV1;EIF4G2;EIF4G1;CD55;BNIP2;RASA1;CASP2;MAPK3;SOS1;PABPC1;JKAMP;FYN;JAK1;AKT1;BID
prerank,VEGFA-VEGFR2 Signaling Pathway WP3888,0.3530447107895742,1.505186021569051,0.0,0.22590107555885228,0.94,83/432,30.41%,CAV1;EIF4G2;SHC1;RACK1;EIF4G1;BRD4;PRDX6;NCK1;SET;MYO1C;RHOC;ACTG1;FLII;RAB11A;PRKAA1;P4HB;NAP1L1;FAM120A;MMP14;RAB5A;FN1;ROCK1;CTNNB1;EIF3H;MAPK3;TPM3;AFDN;TMOD3;RBM39;PABPC1;MAP2K4;CFL1;GRSF1;PRKCI;DNAJB4;SPIRE1;MAPK8;DKK1;CRK;CTNND1;FYN;MAPK14;EWSR1;HSP90AA1;LDHA;RAP1B;RICTOR;AKT1;PRKRA;GRB2;CNP;SSR3;WASF1;DHX36;NDRG1;PTK2;CLTC;ACP1;TRAF3IP2;INPP4B;ITGB1;AP2S1;SLC25A11;VCL;GATA2;MAPKAP1;PAK1;MAP2K3;YWHAE;CRIP2;STAT1;NUMB;TKT;EIF2A;FBXW11;ITCH;OCRL;PRRC2C;RAP1A;HYOU1;ACOT9;PPP3CA;PLOD3
prerank,Prolactin Signaling Pathway WP2037,0.4355869091640926,1.5041958501144295,0.011363636363636364,0.21892523174334477,0.94,18/76,26.91%,SHC1;CTSD;ERBB2;YWHAZ;FLNA;MAPK3;SOS1;MAPK8;FYN;PIK3CB;JAK1;MAPK14;AKT1;GRB2;PTK2;ITGB1;PAK1;STAT1
prerank,Oncostatin M Signaling Pathway WP2374,0.4523296896284392,1.5037267046766243,0.033707865168539325,0.2116277240185666,0.94,14/65,26.93%,SHC1;JUND;MAPK3;SOS1;MAPK8;IL6ST;JAK1;MAPK14;RICTOR;AKT1;GRB2;HIF1A;STAT1;TYK2
prerank,Insulin Signaling WP481,0.40416432948352127,1.498313435608253,0.03260869565217391,0.215079141510655,0.94,27/160,27.79%,SHC1;MAP4K5;AKT2;MYO1C;PRKAA1;MAPK3;EHD1;MAP3K13;SOS1;MAP2K4;PRKCI;PIK3C3;MAPK8;INPPL1;CAP1;CRK;RPS6KA3;PIK3CB;MAPK14;IGF1R;AKT1;GRB2;MINK1;MAP3K2;MAP2K3;MAP3K14;PIK3C2A
prerank,Male infertility WP4673,0.41768277233753803,1.4982489214377255,0.04819277108433735,0.20835791833844702,0.94,14/146,34.50%,CLU;USP8;AHR;CXXC1;CDK9;THBS1;PEMT;KDM3A;XRCC4;UBE2B;RFC1;MTRR;ABLIM1;CDC42BPA
prerank,Hippo-Merlin Signaling Dysregulation WP4541,0.43243698896144966,1.4919101810479063,0.025974025974025976,0.21277204425658522,0.94,23/120,42.28%,PPP1CB;CTNNB1;PPP1R12A;TEAD1;STK3;ITGB4;CDH1;IGF1R;PRKACA;PTK2;ITGB1;PAK1;NRAS;CUL4A;TEAD2;SAV1;MET;DCAF1;EGFR;CCND1;PPP1CA;TAZ;PRKAR1A
prerank,Complement system WP2806,0.5229772138782939,1.4886637816296988,0.0379746835443038,0.2124144441822044,0.95,8/97,20.73%,C3;CD55;LAMA5;CSNK1A1;CD59;LAMC1;THBS1;PRKACA
prerank,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.4702542482571008,1.4761968442280125,0.037037037037037035,0.22657540712768467,0.96,9/86,16.28%,CSNK2A1;RYK;MTDH;CTNNB1;DVL1;CSNK1E;CSNK1A1;DKK1;DVL3
prerank,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.45234791288491355,1.472585235568154,0.04878048780487805,0.2242152466367713,0.96,14/94,30.24%,HNRNPU;CSNK2A1;RYK;CTNNB1;DVL1;CSNK1E;CSNK1A1;DKK1;DVL3;HNRNPK;ATF3;SENP2;FZD6;CTBP2
prerank,Mitochondrial complex I assembly model OXPHOS system WP4324,-0.34959584298743823,-1.4709500196719747,0.0,0.18632773938795658,0.65,8/56,13.06%,NDUFA13;NDUFA1;ECSIT;NDUFB7;NDUFB2;NDUFA2;DMAC2;DMAC1
prerank,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.39213273528467685,1.4703906233083748,0.02197802197802198,0.22134478117484963,0.96,20/160,20.01%,SHC1;AKT2;FN1;CLDN7;CTNNB1;MAPK3;CRB3;CTDSP1;TJP1;TGFBR2;SOS1;MAP2K4;MAPK8;RBPJ;CDH1;PIK3CB;MAPK14;AKT1;GRB2;RBBP4
prerank,PDGFR-beta pathway WP3972,0.5188311148237874,1.4571742020906038,0.05128205128205128,0.23818988112244263,0.98,8/29,19.36%,SHC1;RASA1;MAPK3;SOS1;MAP2K4;MAPK8;JAK1;GRB2
prerank,T-cell receptor (TCR) signaling pathway WP69,0.49180136436198313,1.4563474938702752,0.036585365853658534,0.23299020230811593,0.98,15/90,27.84%,SHC1;IKBKG;NCK1;MAPK3;SOS1;MAPK8;CRK;FYN;MAPK14;BCL10;AKT1;GRB2;PAK1;MAP3K14;RIPK2
prerank,Ciliary landscape WP4352,0.3572164111814138,1.456304412734787,0.01098901098901099,0.22716544725041302,0.98,49/216,37.25%,DDX5;CNOT1;UBE2H;COPS2;CTNNB1;DYNC1I2;EXOC5;HSPB11;AIMP1;ARFGAP3;COPS7B;MYL6B;SMC4;COPS6;EHBP1;PSMD8;UBE2D2;IFT57;RAB14;RANBP9;DVL3;NDUFA5;CNOT9;EXOC3;TIPRL;YAP1;PSMC6;TRAF3IP1;DYNC1H1;WDR26;CALM1;HTRA2;EXOC7;PAFAH1B1;COPS4;IFT52;LRPPRC;CTBP2;HDAC2;MAPRE2;RHBDD2;DNPEP;IFT74;RAC1;COPS3;LZTFL1;YPEL5;COPS7A;TNKS1BP1
prerank,B Cell Receptor Signaling Pathway WP23,0.4508948129674568,1.4464968383795138,0.024691358024691357,0.23774299579200656,0.98,14/97,19.36%,SHC1;IKBKG;NCK1;GTF2I;CD81;SOS1;PTPN18;MAPK8;CRK;FYN;MAPK14;BCL10;AKT1;GRB2
prerank,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.42207477288701295,1.4405163789839248,0.08235294117647059,0.24472616518875667,0.98,14/84,19.36%,SHC1;RRAS2;AKT2;ERBB2;MAPK3;PDGFB;SOS1;AXL;ERBB3;PIK3CB;JAK1;IGF1R;AKT1;GRB2
prerank,IL-3 signaling pathway WP286,0.4731673731982488,1.4374841961340221,0.04819277108433735,0.24507247888205236,0.98,11/49,20.73%,SHC1;MAPK3;SOS1;YWHAQ;MAPK8;FYN;JAK1;AKT1;GRB2;YWHAB;PRKACA
prerank,Small cell lung cancer WP4658,0.4143646141870292,1.4345996696091767,0.07058823529411765,0.2470122513785483,0.98,14/96,24.11%,LAMA3;IKBKG;AKT2;SKP1;FN1;LAMA5;LAMC1;PIK3CB;AKT1;BID;PTK2;ITGB1;CDK4;TRAF4
prerank,mRNA Processing WP411,0.3737448869632213,1.4313905583708653,0.0,0.248341331654997,0.98,44/126,38.33%,HNRNPU;HNRNPH1;NONO;PABPN1;SNRPA;SRSF3;PRPF4B;SF3B1;RNPS1;RBM39;SF3A1;DHX15;HNRNPL;SNRPD3;PTBP1;SNRNP70;HNRNPK;TXNL4A;FUS;RNMT;PRPF40A;CSTF1;PRMT2;HNRNPC;CLK1;SNRPE;CPSF2;SRRM1;NXF1;SNU13;CLK3;TMED10;SRSF10;PRPF8;SPOP;RBM5;PAPOLA;SRSF2;SFPQ;SRSF5;U2AF2;CDC40;SF3A3;PRMT1
prerank,Glycogen Synthesis and Degradation WP500,0.5220694297578977,1.426091621323532,0.0684931506849315,0.25448687032457334,0.98,8/40,27.37%,PPP2R5C;PPP2R5E;PPP2R2A;UGP2;PPP2R5A;PYGB;CALM1;AGL
prerank,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.41188841040754987,1.4253326748142403,0.08139534883720931,0.25057874148208037,0.98,17/84,27.26%,IKBKG;AKT2;ROCK1;CTNNB1;DVL1;MAPK3;CDK9;MAP2K4;MAPK8;IL6ST;PIK3CB;MAPK14;IGF1R;AKT1;CALM1;MAP2K3;MAP3K14
prerank,Myometrial relaxation and contraction pathways WP289,0.40100572024305764,1.4128918383292992,0.060240963855421686,0.26748485563685,0.99,14/156,26.34%,DGKZ;GNAS;ACTG1;GABPA;IGFBP6;YWHAZ;CALD1;YWHAQ;ATP2A2;YWHAB;PRKACA;ATF3;CALM1;YWHAE
prerank,MAPK Cascade WP422,0.4840709220168097,1.410789556421239,0.1,0.26539763887617823,1.0,9/33,28.89%,LAMTOR3;MAPK3;SOS1;MAP2K4;MAPK14;GRB2;MAP3K2;MAP2K3;NRAS
prerank,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.3933300329431083,1.3957769446393382,0.08421052631578947,0.29124380457871135,1.0,18/144,19.36%,SHC1;RACK1;IKBKG;CSNK2A1;NCK1;PRKAA1;ADAM17;CTNNB1;DLG1;MAPK3;CFL1;MAPK8;RANBP9;RPS6KA3;FYN;MAPK14;AKT1;GRB2
prerank,DNA damage response (only ATM dependent) WP710,0.40942372911652036,1.3949782614119846,0.07228915662650602,0.2873842480112177,1.0,15/110,19.36%,SHC1;AKT2;ERBB2;PPP2R5C;CDKN2A;CTNNB1;PPP2R5E;DVL1;SOS1;PIK3C3;MAPK8;DVL3;PIK3CB;AKT1;GRB2
prerank,Lipid Metabolism Pathway WP3965,0.5037277364717372,1.3929965492133112,0.1232876712328767,0.28616945952324757,1.0,5/29,20.73%,AKT2;PRKAA1;ACLY;AKT1;PRKACA
prerank,PI3K-Akt signaling pathway WP4172,0.3492299861259124,1.3927075431070606,0.06382978723404255,0.28143800570891647,1.0,29/340,24.08%,LAMA3;IKBKG;AKT2;COL6A1;PRKAA1;PPP2R5C;FN1;LAMA5;PPP2R5E;PPP2R2A;IFNAR1;MAPK3;PDGFB;HSP90B1;SOS1;ITGB4;PPP2R5A;LAMC1;PIK3CB;JAK1;IGF1R;THBS1;HSP90AA1;AKT1;GRB2;PTK2;KITLG;ITGB1;CDK4
prerank,Head and Neck Squamous Cell Carcinoma WP4674,0.4084743321859056,1.39154927437112,0.10588235294117647,0.2790671247126286,1.0,16/73,28.89%,AKT2;ERBB2;PRKAA1;CUL3;CDKN2A;FKBP1A;CTNNB1;TGFBR2;PIK3CB;IGF1R;RICTOR;AKT1;CDK4;MAPKAP1;NUMB;NRAS
prerank,Wnt Signaling Pathway WP363,0.4261457712693222,1.3811331547548158,0.075,0.2939472611410303,1.0,9/52,19.26%,CSNK1D;RYK;CTNNB1;DVL1;CSNK1E;CSNK1A1;MAPK8;DVL3;AKT1
prerank,IL-2 signaling pathway WP49,0.4895416748713537,1.3786018294990081,0.05952380952380952,0.2931235038268316,1.0,7/42,19.36%,SHC1;MAPK3;SOS1;FYN;JAK1;AKT1;GRB2
prerank,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.4751387673024767,1.378465386119576,0.05714285714285714,0.2883950494598545,1.0,8/58,18.08%,FKBP1A;CTNNB1;MAPK3;TGFBR2;LTBP3;TGIF1;JAK1;THBS1
prerank,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.488120811867896,1.3773429140928248,0.06666666666666667,0.28545734213374785,1.0,11/35,33.90%,TEAD1;STK3;YWHAQ;MAPK14;NDRG1;YAP1;MOB1A;RAP1A;TEAD2;SAV1;RAC1
prerank,Interferon type I signaling pathways WP585,0.45062087401246687,1.3762367111407825,0.07792207792207792,0.2826192181068313,1.0,15/54,33.90%,RACK1;EIF4A1;PIAS1;IFNAR1;CRK;FYN;JAK1;MAPK14;MAPKAP1;MAP2K3;STAT1;TYK2;RAP1A;EIF4B;RAC1
prerank,Kit receptor signaling pathway WP304,0.4298114703341851,1.3751031436625745,0.10112359550561797,0.2790889780505075,1.0,11/59,22.12%,SHC1;MAPK3;SOS1;MAPK8;CRK;RPS6KA3;FYN;MAPK14;AKT1;GRB2;KITLG
prerank,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.4604856997609174,1.3736425560350218,0.10126582278481013,0.27644830668157566,1.0,10/55,40.01%,NAP1L1;CTNNB1;CSNK1A1;LMNA;CDK4;FNTA;ACTB;TARBP2;TGFB2;SMAD3
prerank,Regulatory circuits of the STAT3 signaling pathway WP4538,0.4318991341653116,1.371439265699236,0.047619047619047616,0.2765575155884794,1.0,11/78,26.93%,TRIM28;IFNAR1;MAPK3;MAPK8;STMN1;IL6ST;JAK1;MAPK14;RICTOR;MAPKAP1;TYK2
prerank,Wnt signaling WP428,0.3970883333848593,1.3649496119867568,0.03896103896103896,0.2858416594550652,1.0,10/115,16.28%,CSNK2A1;RYK;CTNNB1;DVL1;DAAM1;CSNK1E;CSNK1A1;MAPK8;DKK1;DVL3
prerank,ErbB signaling pathway WP673,0.3831016926137518,1.3491370103181652,0.07228915662650602,0.30460821335850835,1.0,14/91,21.68%,SHC1;NCK1;AKT2;ERBB2;MAPK3;SOS1;MAP2K4;MAPK8;ERBB3;CRK;PIK3CB;AKT1;GRB2;PTK2
prerank,Wnt signaling pathway and pluripotency WP399,0.40323665054056224,1.347568978869595,0.12,0.30228209364390624,1.0,11/102,16.68%,PPP2R5C;CTNNB1;PPP2R5E;DVL1;PPP2R2A;CSNK1E;MAP2K4;PRKCI;DVL3;CTNND1;RACGAP1
prerank,Glioblastoma signaling pathways WP2261,0.3894847931498727,1.3433144731032105,0.13095238095238096,0.30646326374435884,1.0,20/82,37.91%,AKT2;ERBB2;CDKN2A;MAPK3;MAP2K4;PRKCI;ERBB3;PIK3CB;IGF1R;AKT1;GRB2;CDK4;MAP2K3;PIK3C2A;NRAS;NF1;MET;EGFR;PLCG1;CCND1
prerank,Aryl Hydrocarbon Receptor Pathway WP2873,0.47051777862966304,1.3427015447176411,0.13333333333333333,0.30259371070068586,1.0,9/46,35.62%,JUND;UGT1A6;AHR;MGST1;HSP90AA1;PTGES3;CAP2;CDC37;EGFR
prerank,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.44193092616849744,1.3409136651513311,0.09210526315789473,0.30213525107942635,1.0,13/53,27.86%,APP;JUND;YBX3;CUL5;ERBB3;THBS1;AKT1;HSPD1;PTK2;GCLC;NET1;RIPK2;SQSTM1
prerank,Nephrotic syndrome WP4758,0.459823454115206,1.3371522000434881,0.13333333333333333,0.3052816287159701,1.0,8/45,26.60%,MYO1E;ITGB4;LMNA;YARS;CD2AP;PDSS2;ACTN4;SMARCAL1
prerank,Breast cancer pathway WP4262,0.3825588537025968,1.337005745745068,0.07954545454545454,0.30125762837587244,1.0,15/154,19.36%,SHC1;CSNK2A1;AKT2;SKP1;ERBB2;CTNNB1;DVL1;MAPK3;SOS1;NBN;CSNK1A1;DVL3;IGF1R;AKT1;GRB2
prerank,MECP2 and Associated Rett Syndrome WP3584,0.47058142475973763,1.336708013827064,0.07462686567164178,0.2978456056138578,1.0,11/72,34.12%,HNRNPH1;SIN3A;SP3;IGF1R;FUS;AKT1;CNP;FUT8;NCOR1;NF1;UBE3A
prerank,Toll-like Receptor Signaling Pathway WP75,0.4104961815661133,1.3331754855508862,0.12195121951219512,0.3005926625232738,1.0,12/103,19.26%,IKBKG;AKT2;TAB2;IFNAR1;MAPK3;MAP2K4;TBK1;MAPK8;IRF3;PIK3CB;MAPK14;AKT1
prerank,Metapathway biotransformation Phase I and II WP702,0.38683992278926754,1.3318565123270008,0.08860759493670886,0.29922308689593635,1.0,10/183,22.61%,UGT1A6;GPX3;MGST3;TPMT;MGST1;AKR1C1;AKR1C2;NAA50;GSR;COMT
prerank,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.3739305395770987,1.3291374298398657,0.07317073170731707,0.29836893773641476,1.0,24/69,44.22%,SEC24C;PRKAA1;SEC23B;ACLY;SEC23A;AKT1;PRKACA;MED15;SAR1B;KPNB1;YY1;NFYA;SEC24D;SAR1A;SCAP;CDK8;MVD;FDFT1;CYP51A1;FDPS;SQLE;DBI;MDH1;HMGCS1
prerank,Gastrin signaling pathway WP4659,0.36399055573125433,1.3275020022682074,0.10344827586206896,0.29627881362599323,1.0,21/114,25.08%,SHC1;LAMTOR3;CDKN2A;ROCK1;ANXA2;CTNNB1;MAPK3;TJP1;SOS1;YES1;MAPK8;CDH1;CRK;FYN;MAPK14;AKT1;GRB2;PRKACA;PTK2;ITGB1;PAK1
prerank,Leptin signaling pathway WP2034,0.3940662535051402,1.3272775284901475,0.10843373493975904,0.2928462293330683,1.0,14/76,21.68%,SHC1;IKBKG;ERBB2;PRKAA1;ROCK1;MAPK3;SOS1;MAPK8;FYN;JAK1;MAPK14;AKT1;GRB2;PTK2
prerank,Cardiac Hypertrophic Response WP2795,0.4142155967217851,1.3253062204125923,0.1566265060240964,0.29164840352001076,1.0,12/55,30.39%,IKBKG;AKT2;MAPK3;CDK9;MAP2K4;MAPK8;MAPK14;AKT1;CALM1;MAP2K3;MAP3K14;PPP3CA
prerank,22q11.2 copy number variation syndrome WP4657,0.390979832378539,1.3247072598161553,0.09210526315789473,0.2883631984410837,1.0,11/131,25.59%,CUL3;PPP1CB;DROSHA;EMC10;TNPO1;MED15;TANGO2;COMT;KPNB1;NCOR1;XPO1
prerank,Thermogenesis WP4321,0.3715154172061955,1.3240391766130781,0.0975609756097561,0.28545991760351097,1.0,14/108,20.73%,GNAS;ACTG1;ACTL6A;PRKAA1;SMARCD2;ARID1A;SMARCC1;SMARCE1;SOS1;RPS6KA3;MAPK14;KDM3A;GRB2;PRKACA
prerank,Fragile X Syndrome  WP4549,0.37185109190693805,1.3155070348871567,0.11235955056179775,0.29708520179372194,1.0,24/121,30.39%,SHC1;APP;AP2M1;EIF4A1;EIF4G1;EEF1A1;DNM2;CDKN2A;AP2B1;SOS1;FYN;PIK3CB;SLC16A1;AKT1;GRB2;PRKACA;MAP1B;CLTC;AP2S1;ALDH3A2;TECR;SYNGAP1;NF1;PPP3CA
prerank,Osteoblast differentiation WP4787,0.41559152475904854,1.306655495289308,0.10975609756097561,0.30725793057631623,1.0,11/118,28.03%,CTNNB1;MAPK3;PRKCI;PIK3C3;MAPK8;RBPJ;PIK3CB;MAPK14;STAT1;PIK3C2A;FZD6
prerank,RANKL/RANK signaling pathway WP2018,0.4182286561217075,1.3054273577293747,0.1566265060240964,0.3053817415681827,1.0,12/55,33.90%,IKBKG;AKT2;TAB2;MAPK3;MAPK8;MAPK14;AKT1;PTK2;STAT1;SQSTM1;LYN;RAC1
prerank,DNA IR-double strand breaks and cellular response via ATM WP3959,0.4462162927432558,1.2974328187714037,0.09859154929577464,0.3126501758746101,1.0,7/55,21.72%,ACTL6A;TRIM28;CDKN2A;STK3;NBN;BID;YAP1
prerank,TGF-beta Receptor Signaling WP560,0.44399662921366606,1.296241203391329,0.136986301369863,0.3111759218674489,1.0,7/54,18.08%,FKBP1A;CTNNB1;MAPK3;TGFBR2;TGIF1;JAK1;THBS1
prerank,Nuclear Receptors Meta-Pathway WP2882,0.316624298108179,1.2950611796809346,0.04395604395604396,0.3093198572797068,1.0,42/319,35.62%,FTH1;JUND;UGT1A6;PRDX6;SLC5A6;ABHD2;AHR;GPX3;MGST3;GCLM;PDGFB;MGST1;TGFBR2;ACADM;KTN1;G6PD;ENC1;DNAJC15;HSP90AA1;ALAS1;GSR;ARL5B;SLC39A9;SLC7A11;ABCC3;GCLC;CDK4;SMARCA1;PTGES3;SQSTM1;NCOA6;ME1;LRRC8A;GPX2;SLC39A8;PPARA;CAP2;CPT2;CDC37;CDC42EP3;SLC6A6;EGFR
prerank,DNA IR-damage and cellular response via ATR WP4016,0.40906612721286895,1.2921869311364824,0.125,0.3114862973472894,1.0,5/80,10.78%,IKBKG;UBE2D3;TRIM28;HUS1;NBN
prerank,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.3838753019899177,1.2876092462265576,0.13580246913580246,0.31618012093787895,1.0,17/158,26.34%,MAZ;YWHAZ;CTNNB1;ACADM;HSP90B1;MBD1;SP3;ECE1;YWHAQ;HADHA;YWHAB;PRKACA;HSPD1;GATA2;HIF1A;NFYA;YWHAE
prerank,Ras signaling WP4223,0.36574947922538226,1.2835929374792396,0.07954545454545454,0.3218400669427339,1.0,28/184,35.62%,SHC1;IKBKG;RRAS2;AKT2;RAB5A;RASA1;BRAP;MAPK3;AFDN;SOS1;MAPK8;PIK3CB;IGF1R;RAP1B;AKT1;GRB2;PRKACA;PAK1;CALM1;RALBP1;SYNGAP1;NRAS;NF1;RAP1A;MET;RAC1;RASAL2;EGFR
prerank,PDGF Pathway WP2526,0.40628638866900385,1.2813674423305277,0.15476190476190477,0.322334278281485,1.0,11/40,26.91%,SHC1;RASA1;MAPK3;PDGFB;SOS1;MAP2K4;MAPK8;JAK1;GRB2;PAK1;STAT1
prerank,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.3258462636873909,1.2775268547311727,0.12631578947368421,0.32543990769150083,1.0,40/303,35.97%,LAMA3;IKBKG;AKT2;PRKAA1;PPP2R5C;FN1;LAMA5;PPP2R5E;IFNAR1;MAPK3;PDGFB;HSP90B1;SOS1;RAB10;ITGB4;PPP2R5A;LAMC1;RAB14;PIK3CB;JAK1;IGF1R;THBS1;HSP90AA1;AKT1;GRB2;PTK2;KITLG;ITGB1;HIF1A;FOXA1;PIK3C2A;NRAS;MET;TBC1D1;EIF4B;CDC37;LAMB2;PFKFB3;EGFR;PDGFC
prerank,MAPK Signaling Pathway WP382,0.32967141012921847,1.2740340910205952,0.07692307692307693,0.3288663189536449,1.0,36/246,30.39%,IKBKG;JUND;RRAS2;AKT2;LAMTOR3;RASA1;TAB2;FLNA;MAPK3;MKNK2;PDGFB;MAP3K13;STK3;TGFBR2;SOS1;MAP2K4;MAPK8;STMN1;TAOK3;CRK;RPS6KA3;MAPK14;RAP1B;AKT1;GRB2;PPM1A;PRKACA;GNA12;PAK1;MAP3K2;MAP2K3;MAP3K14;NRAS;NF1;RAP1A;PPP3CA
prerank,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.45268774926278155,1.272223421486723,0.14864864864864866,0.32901150321700134,1.0,9/30,40.01%,ERBB2;CTNNB1;TGFBR2;AKT1;NRAS;MET;EGFR;TGFB2;SMAD3
prerank,Histone Modifications WP2369,0.41111482262925536,1.270910787440584,0.10666666666666667,0.32750399070147523,1.0,6/67,11.78%,H3F3B;SET;SETD5;SETD2;NSD1;ASH1L
prerank,Cell cycle WP179,0.3780742551559982,1.2671571649625424,0.16049382716049382,0.3302969282762292,1.0,22/120,37.91%,SKP1;YWHAZ;CDKN2A;ORC4;STAG2;YWHAQ;YWHAB;CDK4;ANAPC2;YWHAE;FZR1;HDAC2;ANAPC13;ANAPC7;CDC16;ANAPC5;ORC3;BUB3;TGFB2;ANAPC11;STAG1;CCND1
prerank,TNF-alpha signaling pathway WP231,0.36152018963380206,1.2587770808437895,0.13793103448275862,0.3434654609145001,1.0,22/92,33.90%,IKBKG;CSNK2A1;SKP1;TAB2;MAPK3;SOS1;MAP2K4;TBK1;MAPK8;HSP90AA1;AKT1;GRB2;OTUD7B;BID;TANK;MAP2K3;MAP3K14;FBXW11;NRAS;RFFL;CDC37;RAC1
prerank,Endochondral Ossification with Skeletal Dysplasias WP4808,0.45856937117517227,1.2532851524800133,0.2,0.34635963492940197,1.0,11/64,44.69%,SLC38A2;IGF1R;AKT1;PRKACA;CALM1;STAT1;TGFB2;CHST11;SOX9;HMGCS1;CTSV
prerank,Endochondral Ossification WP474,0.45856937117517227,1.2532851524800133,0.2,0.34635963492940197,1.0,11/64,44.69%,SLC38A2;IGF1R;AKT1;PRKACA;CALM1;STAT1;TGFB2;CHST11;SOX9;HMGCS1;CTSV
prerank,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.3829225616372691,1.251616505304091,0.17073170731707318,0.34511326362029354,1.0,13/66,30.11%,MYL12B;GNAS;MAPK3;JAK1;MAPK14;IGF1R;RAP1B;AKT1;GNA12;CDK4;MAP2K3;STAT1;RAP1A
prerank,Hepatitis C and Hepatocellular Carcinoma WP3646,0.41159097735572286,1.2501630710103369,0.18518518518518517,0.34389207152955087,1.0,14/49,40.01%,UCHL1;MAPK3;SOS1;MAPK8;JAK1;MAPK14;AKT1;GRB2;HIF1A;RAC1;CCND1;CTTN;CASP3;SMAD3
prerank,NRF2 pathway WP2884,0.34151311916994115,1.249000069632774,0.09090909090909091,0.3423412792069861,1.0,16/146,23.38%,FTH1;UGT1A6;PRDX6;SLC5A6;GPX3;MGST3;GCLM;PDGFB;TGFBR2;G6PD;HSP90AA1;GSR;SLC39A9;SLC7A11;ABCC3;GCLC
prerank,ATM Signaling Network in Development and Disease  WP3878,0.4194130327415909,1.246328050381,0.23376623376623376,0.34292430895201864,1.0,6/45,14.65%,IKBKG;TRIM28;PRKAA1;ATMIN;NBN;G6PD
prerank,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.39642251905484976,1.2435961237951776,0.1891891891891892,0.3454627071503607,1.0,8/70,27.44%,TUBA4A;UBE2J2;UBE2G1;PSMD8;PSMD9;PSMC3;PSMC6;PSMD5
prerank,Retinoblastoma gene in cancer WP2446,0.38369604254907375,1.2431268916990408,0.19230769230769232,0.3429106965681433,1.0,9/87,24.42%,SIN3A;RBBP7;DHFR;STMN1;CCDC6;RBBP4;PRMT2;CDK4;ZNF655
prerank,7q11.23 copy number variation syndrome WP4932,0.34847715997667905,1.2413132917849672,0.1744186046511628,0.34279061745429457,1.0,23/104,30.74%,BRD4;MYO1C;GTF2I;CTNNB1;DEK;MAPK3;SF3B1;BECN1;CFL1;ATPAF2;TSG101;UBE2E3;ATP5PB;GRB2;VPS37A;CLTC;OGDH;UBE2E1;SQSTM1;EIF2A;SMARCA5;HDAC2;TBL2
prerank,G13 Signaling Pathway WP524,0.3872487324814734,1.2408752433292196,0.12987012987012986,0.3403126650707486,1.0,11/39,39.48%,PPP1CB;DIAPH1;ROCK1;CFL1;PIK3CB;ARHGDIB;CALM1;RAC1;CFL2;TNK2;ROCK2
prerank,Senescence and Autophagy in Cancer WP615,0.34472959576561213,1.2288507832457936,0.20930232558139536,0.3580318933385583,1.0,12/105,18.08%,GABARAP;MMP14;FN1;CDKN2A;IFI16;BMI1;BECN1;PIK3C3;IL6ST;MAPK14;IGF1R;THBS1
prerank,IL-6 signaling pathway WP364,0.3899440424377029,1.2274093497455891,0.2235294117647059,0.35700184621900083,1.0,10/43,26.93%,SHC1;MAPK3;SOS1;MAP2K4;IL6ST;JAK1;AKT1;GRB2;STAT1;TYK2
prerank,Common Pathways Underlying Drug Addiction WP2636,0.4507352916862535,1.2242990731667456,0.19480519480519481,0.3571928076294373,1.0,9/42,30.86%,GNAS;ACTG1;PPP1CB;MAPK3;RAP1B;PRKACA;CALM1;RAP1A;ACTB
prerank,AMP-activated protein kinase (AMPK) signaling WP1403,0.38204364899855336,1.2225876830967433,0.21052631578947367,0.35618935849105626,1.0,7/69,19.26%,AKT2;PRKAA1;PIK3C3;ADIPOR1;PIK3CB;STRADB;AKT1
prerank,Apoptosis WP254,0.3596622333500127,1.2101566089309497,0.23529411764705882,0.3755873581221705,1.0,10/84,19.92%,IKBKG;SCAF11;CDKN2A;CASP2;BNIP3L;MAP2K4;IRF3;IGF1R;AKT1;BID
prerank,Ferroptosis WP4313,0.4323083319112373,1.2019230075866123,0.21333333333333335,0.3880444050375605,1.0,8/40,32.64%,FTH1;VDAC2;NCOA4;GCLM;SLC7A11;GCLC;SLC39A8;ACSL4
prerank,Amino Acid metabolism WP3925,0.33603700673955345,1.1937650883915236,0.20689655172413793,0.39869854007215344,1.0,11/91,26.98%,GLS;GCLM;ACADM;ACLY;CPS1;ODC1;LDHA;SDHA;GSR;MPST;OGDH
prerank,MET in type 1 papillary renal cell carcinoma WP4205,0.36035803382736215,1.1927156279179505,0.2619047619047619,0.39798989517127875,1.0,18/59,33.90%,RPL11;AKT2;PRCC;MAPK3;SOS1;STRN;MAPK8;CRK;PIK3CB;RAP1B;AKT1;GRB2;PTK2;PAK1;NRAS;RAP1A;MET;RAC1
prerank,IL-1 signaling pathway WP195,0.4014098859771425,1.1898900665447953,0.21794871794871795,0.3991569672351755,1.0,12/55,27.86%,IKBKG;TAB2;MAPK3;UBE2V1;MAP2K4;MAPK8;MAPK14;AKT1;MAP3K2;MAP2K3;MAP3K14;SQSTM1
prerank,Cytosolic DNA-sensing pathway WP4655,0.3703167597638774,1.1849296299069045,0.2077922077922078,0.40584498876358377,1.0,13/75,42.74%,IKBKG;POLR2F;TBK1;POLR2H;IRF3;POLR2E;TRIM25;POLR2L;ATG12;CYLD;POLR3F;POLR3C;ADAR
prerank,Endometrial cancer WP4155,0.3571701819756346,1.1818955681905319,0.21951219512195122,0.4088571126284864,1.0,9/63,19.36%,AKT2;ERBB2;CTNNB1;MAPK3;SOS1;CDH1;PIK3CB;AKT1;GRB2
prerank,Melanoma WP4685,0.35371304352524296,1.173892004354739,0.225,0.42190390314062726,1.0,15/68,29.99%,AKT2;LAMTOR3;CDKN2A;MAPK3;SOS1;CDH1;PIK3CB;AKT1;GRB2;VCL;CDK4;PAK1;CALM1;NRAS;NF1
prerank,AGE/RAGE pathway WP2324,0.37575342138539486,1.1709605151741123,0.2597402597402597,0.4235287999583972,1.0,16/66,40.52%,SHC1;MMP14;DIAPH1;ROCK1;MAPK3;MAPK8;MAPK14;AKT1;HIF1A;STAT1;RAC1;EGFR;ATF2;CASP3;SMAD3;DDOST
prerank,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.38569947944035204,1.165323774026421,0.225,0.431671370459914,1.0,9/49,27.26%,TAB2;MAPK3;MKNK2;MAP2K4;MAPK8;MAPK14;TANK;MAP2K3;MAP3K14
prerank,Interleukin-11 Signaling Pathway WP2332,0.37383991840066566,1.1638286092713808,0.3076923076923077,0.4313193297144206,1.0,10/44,26.93%,PIAS1;MAPK3;YES1;IL6ST;FYN;JAK1;AKT1;GRB2;STAT1;TYK2
prerank,Type 2 papillary renal cell carcinoma WP4241,0.39030672340845374,1.1528483508406007,0.26666666666666666,0.44872307515258153,1.0,6/34,16.21%,DIAPH1;PRCC;PDGFB;EGLN3;SETD2;ELOB
prerank,Androgen receptor signaling pathway WP138,0.30799007274338974,1.1500793402652083,0.23170731707317074,0.4493977721632612,1.0,12/90,12.26%,CAV1;RACK1;ROCK1;CTNNB1;NCOA4;PIAS1;FLNA;SIN3A;SMARCE1;RNF6;RNF14;TGIF1
prerank,Notch Signaling WP268,0.36809055250668143,1.149438666755911,0.29333333333333333,0.4476629614065789,1.0,7/45,16.28%,LFNG;ADAM17;DVL1;DTX4;NUMBL;RBPJ;DVL3
prerank,Signaling of Hepatocyte Growth Factor Receptor WP313,0.39879478771862775,1.142097397485304,0.27710843373493976,0.45899411482561464,1.0,12/34,32.51%,RASA1;MAPK3;SOS1;MAPK8;CRK;RAP1B;GRB2;PTK2;ITGB1;PAK1;RAP1A;MET
prerank,Electron Transport Chain (OXPHOS system in mitochondria) WP111,-0.2351355466932462,-1.132694315971493,0.16666666666666666,0.836623889437315,1.0,11/103,9.48%,NDUFA1;COX5B;ATP5ME;NDUFB7;ATP5F1E;ATP5IF1;NDUFB2;COX7C;NDUFA2;COX5A;NDUFS7
prerank,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.3940446899976643,1.1220773805218176,0.33766233766233766,0.49440641963653525,1.0,5/37,20.01%,CHD4;H3F3B;RBBP7;MTA3;RBBP4
prerank,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.37815666809928006,1.1173935058702829,0.34146341463414637,0.49956730390999926,1.0,7/42,19.67%,AKT2;CTNNB1;MAPK3;MAPK8;MAPK14;AKT1;TNFRSF12A
prerank,Pathways in clear cell renal cell carcinoma WP4018,0.3248693216447872,1.1100441924910889,0.3493975903614458,0.5091999799293438,1.0,18/85,39.81%,ENO1;TPI1;PDGFB;SETD2;ACLY;PGM2;BAP1;LDHA;AKT1;PLOD2;HIF1A;SQSTM1;ME1;BHLHE41;EGFR;TGFB2;GAPDH;KDM5C
prerank,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.35513359570619785,1.097191729287753,0.3717948717948718,0.5284546849185744,1.0,8/60,22.25%,DDX3X;IKBKG;AZI2;TBK1;MAPK8;IRF3;MAPK14;TANK
prerank,Integrin-mediated Cell Adhesion WP185,0.3105431077190997,1.0922434523483366,0.3448275862068966,0.5345123158297245,1.0,17/101,26.27%,CAV1;SHC1;AKT2;ROCK1;CAPNS1;SOS1;ITGB4;CRK;FYN;RAP1B;AKT1;GRB2;PTK2;ITGB1;VCL;PAK1;MAP2K3
prerank,Proteasome Degradation WP183,0.31107867675680884,1.0903980666572566,0.3764705882352941,0.5338501479639077,1.0,12/62,23.00%,PSMA5;UBE2D3;UBB;UCHL1;PSMD8;UBE2D2;PSMD9;PSMC3;UBE2D1;RPN2;PSMC6;UBE2B
prerank,Fatty acid beta-oxidation WP143,0.3665824775148051,1.0902886597179813,0.3170731707317073,0.529955120917688,1.0,9/34,40.93%,TPI1;ACADM;HADHA;ACADVL;HADHB;ACSL4;CPT2;DLD;GPD2
prerank,Oxidative phosphorylation WP623,-0.2580833036063401,-1.0889727121177262,0.35714285714285715,0.7687561697926949,1.0,7/60,9.48%,ATP5ME;NDUFA11;NDUFB7;ATP5F1E;NDUFB2;NDUFA2;NDUFS7
prerank,16p11.2 distal deletion syndrome WP4950,0.3902793269063991,1.080584652523602,0.3611111111111111,0.5439097131332203,1.0,4/31,9.39%,C3;RAB5A;CD81;ATXN2L
prerank,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.3732209991823066,1.079878923977074,0.35135135135135137,0.5414172675020097,1.0,9/71,28.89%,CAV1;MAPK3;SP3;MAPK8;JAK1;MAPK14;STAT1;TYK2;NRAS
prerank,IL-4 signaling pathway WP395,0.35860782194271607,1.0789040801672871,0.3424657534246575,0.5393142853116997,1.0,10/54,26.93%,SHC1;FLNA;MAPK3;SOS1;JAK1;MAPK14;AKT1;GRB2;STAT1;TYK2
prerank,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.3599796202058346,1.0756523571981964,0.35802469135802467,0.5419627793949248,1.0,16/46,47.55%,FADS2;DHCR24;EBP;GGPS1;DHCR7;SOAT1;ACSL4;MVD;FDFT1;CYP51A1;FDPS;SQLE;HMGCS1;LBR;NSDHL;MSMO1
prerank,ESC Pluripotency Pathways WP3931,0.3294990542717159,1.0746816288567067,0.36470588235294116,0.5395396298713018,1.0,13/116,28.03%,AKT2;CTNNB1;DVL1;PDGFB;SOS1;IL6ST;DVL3;JAK1;AKT1;GRB2;MAP2K3;ACTR2;FZD6
prerank,Nonalcoholic fatty liver disease WP4396,-0.2128150172615573,-1.0730560031409515,0.25,0.6678183613030603,1.0,14/155,10.28%,NDUFA13;NDUFA1;COX5B;NDUFA11;NDUFB7;COX7B2;AKT3;PIK3CA;NDUFB2;COX7C;NDUFA2;COX5A;NDUFS7;NR1H3
prerank,Calcium Regulation in the Cardiac Cell WP536,0.3285817319837606,1.0723689193033255,0.38461538461538464,0.5402527955842602,1.0,9/150,26.34%,GNAS;YWHAZ;FKBP1A;YWHAQ;ATP2A2;YWHAB;PRKACA;CALM1;YWHAE
prerank,Cytoplasmic Ribosomal Proteins WP477,0.2835061754807599,1.0644619934044857,0.4148936170212766,0.5519012974041656,1.0,17/89,17.18%,RPL32;RPL11;RPL8;RPL37;RPL17;RPL15;RPL29;RPL13;RPL4;RPL22;RPSA;RPLP0;RPS20;RPS27;RPL41;RPS6KA3;RPL28
prerank,ATM Signaling Pathway WP2516,0.38673632111811085,1.0626972986947916,0.373134328358209,0.5523454731612397,1.0,4/40,10.78%,IKBKG;CASP2;TLK1;NBN
prerank,Mesodermal commitment pathway WP2857,0.29155273405558446,1.0532633251066252,0.4268292682926829,0.5674500151724604,1.0,16/147,31.01%,TRIM28;PIAS1;TEAD1;SETD2;PHF6;DKK1;CUL4B;CCDC6;PARP8;PRKACA;YAP1;AHDC1;FOXA1;CTBP2;TEAD2;AEBP2
prerank,Chemokine signaling pathway WP3929,0.3015264220529355,1.0527154169386823,0.40229885057471265,0.5645972578617616,1.0,17/164,30.75%,SHC1;IKBKG;AKT2;ROCK1;MAPK3;SOS1;CRK;PIK3CB;RAP1B;AKT1;GRB2;PTK2;PAK1;STAT1;NRAS;RAP1A;LYN
prerank,Autophagy WP4923,0.3584135522915266,1.0469186490373281,0.3855421686746988,0.5713416681348417,1.0,3/30,13.61%,PRKAA1;BECN1;PIK3C3
prerank,Notch Signaling Pathway Netpath WP61,0.3495382001238252,1.0434687064595416,0.44155844155844154,0.5734529808166816,1.0,12/61,37.91%,SKP1;ADAM17;NUMBL;RBPJ;AKT1;HIF1A;NCOR1;NUMB;ITCH;HDAC2;NCOR2;CCND1
prerank,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.3105087428965065,1.0427279103425997,0.4074074074074074,0.5711916188078567,1.0,7/73,13.83%,AKT2;CTNNB1;MAPK3;TGFBR2;CSNK1A1;TBK1;MAPK8
prerank,Rett syndrome causing genes WP4312,0.34396388868133376,1.0425837677778838,0.4594594594594595,0.5676592904869255,1.0,8/48,28.17%,CHD4;TBL1XR1;CRK;GPS2;NCOR1;TRRAP;SMARCA1;SYNGAP1
prerank,Nanoparticle-mediated activation of receptor signaling WP2643,0.35742662708861705,1.0420445801222686,0.4,0.5644986598814747,1.0,8/28,28.89%,FN1;SOS1;MAPK8;MAPK14;GRB2;PTK2;ITGB1;NRAS
prerank,Amyotrophic lateral sclerosis (ALS) WP2447,0.3522391063132767,1.0299978162238959,0.4155844155844156,0.5832968070400215,1.0,9/38,44.26%,RAB5A;MAPK14;DERL1;BID;PPP3CA;RAC1;CASP3;BAX;CAT
prerank,16p11.2 proximal deletion syndrome WP4949,0.3057494555896471,1.0289646056326478,0.4605263157894737,0.5815084614943006,1.0,9/74,17.65%,MAZ;PPP4R3B;PARP4;TMEM219;MAPK3;CCT3;BPTF;CCDC6;PPP4R2
prerank,Neovascularisation processes WP4331,0.3743204800725351,1.0250776761439253,0.425,0.5854465217728766,1.0,6/37,24.26%,MAPK3;PDGFB;MAPK8;AKT1;KITLG;HIF1A
prerank,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.3519185239227718,1.0241963761114687,0.5263157894736842,0.583116985288333,1.0,10/66,33.08%,LARP1;IFNAR1;TBK1;AP1G1;IRF3;JAK1;TANK;STAT1;HDAC2;TRIM25
prerank,miRNA regulation of DNA damage response WP1530,0.33225280117995803,1.0232190361155205,0.4533333333333333,0.5815998136879931,1.0,12/71,39.96%,TLK1;NBN;TLK2;BID;CDK4;RFC1;PML;CCNG1;RAD1;CCND1;CASP3;BAX
prerank,Aryl Hydrocarbon Receptor Netpath WP2586,0.3579265414057227,1.0184538195827757,0.4146341463414634,0.5876333801224799,1.0,8/46,35.62%,AHR;HSP90AA1;GCLC;NRAS;NF1;CDC37;NCOR2;EGFR
prerank,Pancreatic adenocarcinoma pathway WP4263,0.2819717798255541,1.0107953200779096,0.475,0.5974445477978777,1.0,14/89,27.75%,IKBKG;AKT2;ERBB2;CDKN2A;MAPK3;TGFBR2;MAPK8;PIK3CB;JAK1;AKT1;CDK4;PAK1;STAT1;RALBP1
prerank,G Protein Signaling Pathways WP35,0.32849863384598527,1.0045674057172753,0.5185185185185185,0.6058256117260129,1.0,10/93,30.39%,GNAS;PRKCI;AKAP11;PRKACA;AKAP10;GNA12;CALM1;NRAS;PRKD3;PPP3CA
prerank,Integrated breast cancer pathway WP1984,0.26413384753830216,0.9855404065322154,0.5747126436781609,0.63594905098708,1.0,22/152,30.13%,CSNK1D;PPP4R3B;AHR;CTNNB1;UBE2F;PIAS1;TPR;MAP3K13;TGFBR2;CDH1;JAK1;ODC1;AKT1;BID;CDK4;ZNF655;PAK1;STAT1;PML;NF1;RAP1A;PHB
prerank,DNA damage response WP707,0.3159268229666602,0.9849444891505923,0.44871794871794873,0.6326289162021992,1.0,11/68,39.96%,TLK1;NBN;TLK2;BID;CDK4;RFC1;PML;RAD1;CCND1;CASP3;BAX
prerank,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.34747581570221514,0.9816270218466607,0.5066666666666667,0.6344622517133712,1.0,9/50,34.12%,AKT2;PRKAA1;MAPK3;PIK3CB;AKT1;SYNGAP1;NRAS;NF1;UBE3A
prerank,Proximal tubule transport WP4917,-0.2907123708466753,-0.9705844563670469,0.5263157894736842,0.8341559723593288,1.0,4/57,13.63%,ATP1A1;ATP6V1G1;SLC9A3;ATP6V1D
prerank,Phosphoinositides metabolism WP4971,0.32705989888105785,0.9675689013664828,0.44871794871794873,0.6555420452135049,1.0,9/49,37.30%,PLCD3;PIK3C3;PIK3CB;MTMR2;MTMR6;PIK3C2A;OCRL;MTMR1;PLCG1
prerank,Netrin-UNC5B signaling pathway WP4747,0.31876549437455853,0.9673911031205944,0.5301204819277109,0.6517902336855761,1.0,8/52,21.72%,NTN4;MAPK3;ITGB4;FYN;MAPK14;AKT1;PTK2;YAP1
prerank,Non-small cell lung cancer WP4255,0.29287686384872286,0.96710194771623,0.5609756097560976,0.6480115647864054,1.0,17/72,39.96%,AKT2;ERBB2;CDKN2A;MAPK3;SOS1;PIK3CB;AKT1;GRB2;BID;CDK4;NRAS;EGFR;EML4;PLCG1;CCND1;CASP3;BAX
prerank,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.34221177889927623,0.9645737893040853,0.4875,0.6480179782660004,1.0,5/36,17.44%,MAPK3;MAP2K4;MAPK8;RPS6KA3;MAPK14
prerank,Spinal Cord Injury WP2431,0.28153026691189587,0.9636829096885711,0.4383561643835616,0.6464945789153168,1.0,17/118,46.74%,RHOC;FKBP1A;MAPK3;CDK4;PTPRA;CCNG1;PPP3CA;RAC1;EGFR;CCND1;CHST11;CASP3;ROCK2;SOX9;ZFP36;CD47;RTN4
prerank,Regulation of toll-like receptor signaling pathway WP1449,0.2730093609270688,0.9596917997537858,0.5813953488372093,0.6509264715890252,1.0,16/139,27.86%,IKBKG;AKT2;TAB2;IFNAR1;MAPK3;MAP2K4;TBK1;MAPK8;IRF3;PIK3CB;MAPK14;AKT1;TMED7;MAP2K3;STAT1;SQSTM1
prerank,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.3163245996738721,0.9589680516425297,0.5128205128205128,0.6488282666635966,1.0,5/44,14.31%,PRKAA1;GTPBP2;BECN1;PIK3C3;PANK2
prerank,IL-18 signaling pathway WP4754,0.23645704267956508,0.957197720557061,0.5425531914893617,0.6479713347780377,1.0,13/272,9.66%,NACA;ITM2C;PRKAA1;MEPCE;MMP14;FN1;CD81;CTNNB1;PRCC;DEK;ENO1;MAPK3;B2M
prerank,Target Of Rapamycin (TOR) Signaling WP1471,0.32457637948099627,0.9403038632444952,0.5789473684210527,0.6764845551666189,1.0,5/36,24.95%,PRKAA1;FKBP1A;RICTOR;AKT1;MAPKAP1
prerank,Adipogenesis WP236,-0.209118638977332,-0.9276833961981478,0.75,0.8274573402905092,1.0,8/130,10.28%,MEF2D;CISD1;BMP1;GADD45A;BSCL2;SPOCK1;KLF15;NR1H3
prerank,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.31660842898483565,0.921563047420835,0.5609756097560976,0.7045856363741717,1.0,7/47,19.26%,MAPK3;YES1;MAPK8;FYN;JAK1;MAPK14;AKT1
prerank,Modulators of TCR signaling and T cell activation WP5072,0.3107747065232322,0.9041523137174476,0.6,0.7303151376198344,1.0,8/61,22.65%,DGKZ;IKBKG;CUL5;ELOB;BCL10;AKT1;GRB2;RPRD1B
prerank,Thyroid hormones production and their peripheral downstream signaling effects WP4746,-0.2009272438148603,-0.8990817645637139,0.5882352941176471,0.7918928923988153,1.0,10/95,18.37%,AKT3;PIK3CA;TSC2;PAX8;MAP2K1;BAD;TP53;SIRT6;DIO2;MAPK1
prerank,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.2750396296972523,0.8986195486073402,0.6144578313253012,0.7373057580933255,1.0,11/50,39.96%,CDKN2A;MAP2K4;MAPK8;MAPK14;HSP90AA1;BID;MAP2K3;EGFR;ATF2;CCND1;BAX
prerank,Joubert Syndrome WP4656,0.28507296975327834,0.8977818014268164,0.6133333333333333,0.7342875786141693,1.0,4/76,7.92%,TCTN1;TCTN3;DVL1;FLNA
prerank,Metabolic reprogramming in colon cancer WP4290,0.2989969140450444,0.8882061322171658,0.6410256410256411,0.7462799868051847,1.0,7/42,27.31%,GLS;ENO1;ACLY;G6PD;LDHA;SDHB;TKT
prerank,Vitamin D Receptor Pathway WP2877,0.26939122624831746,0.8873324099007778,0.654320987654321,0.7431075080547338,1.0,10/182,26.67%,CDKN2A;TIMP2;CLPTM1L;SERPINB1;KLK6;G6PD;CD9;LPGAT1;HIF1A;MYO9B
prerank,Glucocorticoid Receptor Pathway WP2880,0.30308525343293335,0.8731190115851359,0.6533333333333333,0.7605719501064802,1.0,9/70,34.14%,ABHD2;KTN1;ENC1;DNAJC15;HSP90AA1;ARL5B;PTGES3;LRRC8A;CDC42EP3
prerank,Fas ligand pathway and stress induction of heat shock proteins WP314,0.28230216363254723,0.8726106451149593,0.6125,0.7570146953900911,1.0,9/42,30.86%,ACTG1;MAP2K4;MAPK8;LMNA;ARHGDIB;PAK1;RIPK2;DFFA;ACTB
prerank,Neural Crest Differentiation WP2064,0.28545588466964195,0.8695810530151773,0.631578947368421,0.7582184159951447,1.0,8/101,30.66%,CTNNB1;DVL1;RBPJ;CDH1;DVL3;ITGB1;CTBP2;HDAC2
prerank,DNA Repair Pathways Full Network WP4946,0.2463905465443442,0.8533224594643063,0.6428571428571429,0.781333812517433,1.0,18/120,40.83%,XRCC6;NBN;CUL4B;MNAT1;GTF2H1;MPG;XRCC4;FANCL;POLM;RFC1;MBD4;CUL4A;RAP1A;ERCC5;RPA1;RAD23B;NHEJ1;TDG
prerank,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.3073163717457407,0.8528642756709436,0.684931506849315,0.7772528531940172,1.0,5/37,24.26%,BNIP3L;SLC16A1;LDHA;BID;HIF1A
prerank,miRNA regulation of prostate cancer signaling pathways WP3981,0.27822248644105807,0.8331379293501794,0.7066666666666667,0.8062334755617314,1.0,4/33,19.36%,IKBKG;CTNNB1;SOS1;GRB2
prerank,Copper homeostasis WP3286,0.2826208669807496,0.8265942146038957,0.7083333333333334,0.8112227609131052,1.0,2/52,3.93%,APP;ADAM17
prerank,Genes related to primary cilium development (based on CRISPR) WP4536,0.24232092820142273,0.8136305138135959,0.7875,0.8287441323787795,1.0,13/103,39.88%,TCTN1;HSPB11;TCTN3;IFT57;TULP3;TRAF3IP1;IFT52;IFT74;OFD1;KIAA0753;LZTFL1;DYNLL1;BBS10
prerank,One-carbon metabolism and related pathways WP3940,0.2557791347042666,0.8058623466651272,0.7317073170731707,0.8359662379693753,1.0,6/52,23.38%,GPX3;GCLM;AHCYL1;PEMT;GSR;GCLC
prerank,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.2724382665517636,0.8014305376535668,0.7532467532467533,0.8380514929960292,1.0,4/47,13.83%,PPP1CB;PPP1R12A;PPP1R7;MAPK8
prerank,Bladder cancer WP2828,0.2534045335998074,0.7694104605270247,0.7625,0.8786761434203755,1.0,8/40,37.91%,ERBB2;CDKN2A;CDH1;THBS1;CDK4;NRAS;EGFR;CCND1
prerank,p53 transcriptional gene network WP4963,0.2755221589496952,0.759125115728478,0.7974683544303798,0.8888441370534935,1.0,9/67,41.60%,THBS1;SLC7A11;TRAF4;PML;CCNG1;ERCC5;NCF2;BAX;LIF
prerank,Energy Metabolism WP1541,0.2471902702997133,0.7586925999449471,0.7534246575342466,0.88454987912151,1.0,2/47,3.31%,PRKAA1;GABPA
prerank,Eukaryotic Transcription Initiation WP405,0.238133526682267,0.7491932014432117,0.8375,0.8898820173535241,1.0,7/43,35.66%,POLR2F;POLR2H;MNAT1;GTF2H1;POLR2B;POLR2E;GTF2A2
prerank,Pyrimidine metabolism WP4022,-0.16411561104121064,-0.7384277864845823,0.9285714285714286,0.985521553142481,1.0,27/85,74.28%,ZNRD1;NT5C;POLR2I;DUT;POLR2A;CTPS2;POLR1C;POLR2C;NME3;POLE4;POLR2J3;UCK1;POLR3D;POLD4;NME1-NME2;POLR3H;UCKL1;POLE2;CTPS1;POLD3;POLR1D;POLR3C;POLR3F;POLR2L;POLR2E;POLR2B;NME2
prerank,Selenium Micronutrient Network WP15,0.22526964287652945,0.7310405840233525,0.821917808219178,0.9071472475101569,1.0,6/89,30.53%,GPX3;SELENOF;KYNU;GSR;SELENOT;GPX2
prerank,p38 MAPK Signaling Pathway WP400,0.23244585361389408,0.7168887511305587,0.8648648648648649,0.9192071869397758,1.0,10/34,38.58%,SHC1;MAP2K4;MAPK14;GRB2;STAT1;RAC1;MAPKAPK5;TGFB2;ATF2;MKNK1
prerank,Ectoderm Differentiation WP2858,0.20113523073143497,0.7160966605593162,0.8823529411764706,0.9158421714475526,1.0,20/138,49.10%,NUMA1;CTNNB1;WDR44;STX16;FYN;UBTF;TRIM33;OGT;SGSM3;BAZ1A;CAP2;LY6E;SKIL;SERPINB6;TCF3;RIT1;PHF8;HDAC10;PPARD;ZBTB7B
prerank,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.2142283399194677,0.6970720116609361,0.8292682926829268,0.9337540215892576,1.0,4/46,12.31%,PLEC;MAPK3;SOS1;CFL1
prerank,Nucleotide Excision Repair WP4753,0.21525559526595384,0.6691092394308448,0.8888888888888888,0.9582128024496241,1.0,8/44,37.61%,CUL4B;MNAT1;GTF2H1;RFC1;CUL4A;ERCC5;RPA1;RAD23B
prerank,3q29 copy number variation syndrome WP4906,0.22163331077114296,0.6560477016793008,0.92,0.9635478129179451,1.0,9/63,39.54%,DLG1;AKT1;HFE;HIF1A;PIGX;SENP5;MELTF;ADAM10;DYNLL1
prerank,Folate Metabolism WP176,0.21320827922891816,0.6261523278415561,0.9066666666666666,0.9795277477832224,1.0,3/69,14.67%,GPX3;DHFR;AHCY
prerank,Ciliopathies WP4803,-0.14066143255072955,-0.6249664875547161,0.9375,0.9703849950641659,1.0,6/183,9.93%,B9D2;B9D1;BBS7;GAS8;XPNPEP3;ADCY6
prerank,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.20668336091826728,0.6176566364084012,0.9178082191780822,0.9794057748504219,1.0,5/32,30.66%,CDK9;NELFB;SUPT4H1;PPP3CA;HDAC2
prerank,Glycolysis and Gluconeogenesis WP534,0.20308397717028223,0.5698424664548518,0.9324324324324325,0.9990135739486695,1.0,11/45,52.45%,ENO1;TPI1;LDHA;FBP1;DLD;GAPDH;MDH1;PDHA1;ALDOA;PC;PFKM
prerank,Apoptosis Modulation and Signaling WP1772,0.17132945825238824,0.5680513676516894,0.9534883720930233,0.9948196885551482,1.0,4/90,8.36%,CDKN2A;CASP2;CAPNS1;MAPK3
prerank,CAMKK2  Pathway WP4874,0.1880106259563511,0.5537295649929042,1.0,0.9949813643165298,1.0,6/34,34.56%,MAPK3;DNM1L;CALM1;SQSTM1;RAC1;ARHGEF7
prerank,Alzheimer's disease WP2059,0.1711304975713492,0.5431609707585281,0.9873417721518988,0.9940686067662703,1.0,3/83,8.36%,APP;ADAM17;MAPK3
prerank,Genotoxicity pathway WP4286,0.1826193411921478,0.512511257159464,0.987012987012987,0.9956556442823037,1.0,4/63,24.66%,DAAM1;RPS27;EI24;TM7SF3
prerank,G1 to S cell cycle control WP45,0.16343656992815456,0.45772606123050147,1.0,0.9976398395090866,1.0,10/64,46.27%,CDKN2A;ORC4;MNAT1;CDK4;RPA1;ORC3;CCND1;TFDP2;CCNB1;CREB1
